Table 1.

Expression of E-tetramer, NKG2A, and CD94 on CD3+ and CD56+ subpopulations of lymphocytes from HTLV-1-infected individuals and healthy control


Subject group

No.

Mean±SD

P, ANOVA or KW

P, Sheffé F
E tetramer positive      
    HAM/TSP   20   9.10±8.09    
    AC   20   12.47±6.67   .059   NA  
    Healthy   22   14.76±7.82    
NKG2A+     
    HAM/TSP   20   6.09±3.60    
    AC   20   9.35±6.73   .24*  .36 (HAM-healthy)  
    Healthy   22   10.87±6.53    
CD94+     
    HAM/TSP   20   14.16±12.02    
    AC   20   14.87±7.16   .27   NA  
    Healthy   22   18.88±9.38    
CD3+ E tetramer positive      
    HAM/TSP   20   2.81±1.87    
    AC   20   7.39±5.85   .001*  .013 (HAM-AC)  
    Healthy   22   6.78±5.37    .03 (HAM-healthy)  
% CD3+NKG2A+     
    HAM/TSP   20   2.94±2.10    
    AC   20   6.60±5.82   .013*  .048 (HAM-healthy)  
    Healthy   22   6.16±4.93    
% CD3+CD94+     
    HAM/TSP   20   3.68±2.39    .013 (HAM-AC)  
    AC   20   8.26±5.64   .003*  .041 (HAM-healthy)  
    Healthy   22   7.62±5.22    
% CD56+CD3- E tetramer positive      
    HAM/TSP   20   7.90±8.07    
    AC   20   7.35±5.57   .12   NA  
    Healthy   22   12.47±9.11    
% CD56+CD3-NKG2A+     
    HAM/TSP   20   5.17±4.19    
    AC   20   5.49±5.49   .15   NA  
    Healthy   22   6.94±4.43    
% CD56+CD3-CD94+     
    HAM/TSP   20   13.40±13.06    
    AC   20   10.63±7.28   .078*  NA  
    Healthy
 
22
 
18.87±11.05
 

 

 

Subject group

No.

Mean±SD

P, ANOVA or KW

P, Sheffé F
E tetramer positive      
    HAM/TSP   20   9.10±8.09    
    AC   20   12.47±6.67   .059   NA  
    Healthy   22   14.76±7.82    
NKG2A+     
    HAM/TSP   20   6.09±3.60    
    AC   20   9.35±6.73   .24*  .36 (HAM-healthy)  
    Healthy   22   10.87±6.53    
CD94+     
    HAM/TSP   20   14.16±12.02    
    AC   20   14.87±7.16   .27   NA  
    Healthy   22   18.88±9.38    
CD3+ E tetramer positive      
    HAM/TSP   20   2.81±1.87    
    AC   20   7.39±5.85   .001*  .013 (HAM-AC)  
    Healthy   22   6.78±5.37    .03 (HAM-healthy)  
% CD3+NKG2A+     
    HAM/TSP   20   2.94±2.10    
    AC   20   6.60±5.82   .013*  .048 (HAM-healthy)  
    Healthy   22   6.16±4.93    
% CD3+CD94+     
    HAM/TSP   20   3.68±2.39    .013 (HAM-AC)  
    AC   20   8.26±5.64   .003*  .041 (HAM-healthy)  
    Healthy   22   7.62±5.22    
% CD56+CD3- E tetramer positive      
    HAM/TSP   20   7.90±8.07    
    AC   20   7.35±5.57   .12   NA  
    Healthy   22   12.47±9.11    
% CD56+CD3-NKG2A+     
    HAM/TSP   20   5.17±4.19    
    AC   20   5.49±5.49   .15   NA  
    Healthy   22   6.94±4.43    
% CD56+CD3-CD94+     
    HAM/TSP   20   13.40±13.06    
    AC   20   10.63±7.28   .078*  NA  
    Healthy
 
22
 
18.87±11.05
 

 

 

% CD3+E tetramer positive means percent of CD3+ cells that are E tetramer positive

% CD56+CD3-E tetramer positive means percent of CD56+CD3- cells that are E tetramer positive

Values represent the mean ± SD. One-factor ANOVA was done when variance of each group was equal by Bartlett test. For multiple comparisons, we used Sheffé F to analyze statistical difference

AC indicates asymptomatic carrier

*

If variance of each group was different, Kruskal-Wallis test was used

or Create an Account

Close Modal
Close Modal